Physician profile
Jeffrey T Deyoung
NPI 1932638822
$1,982.32
in general payments reported to CMS, 2019-2025
10 companies · $144 in 2025
The $144 reported for 2025 was less than what a typical Oral and Maxillofacial Surgery provider received nationally (typical 2025 total: $150).
See the full distribution for Oral and Maxillofacial Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $300 · 2020: $568 · 2021: $190 · 2022: $19.94 · 2023: $98.09 · 2024: $662 · 2025: $144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $616 · Food and Beverage: $247 · Entertainment: $41.61.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $615.71 |
| Food and Beverage | $246.94 |
| Entertainment | $41.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $681.75 | 2020-2024 | Tmj System |
| Medical Device Business Services, INC. | $577.99 | 2019-2020 | |
| Depuy Synthes Sales INC. | $479.85 | 2020-2025 | Trumatch |
| Envista Holdings Corporation | $60.18 | 2025 | Spark |
| Keystone Dental INC. | $41.61 | 2023 | |
| Zimvie INC. | $37.06 | 2023 | |
| Stryker Corporation | $34.56 | 2025 | Smartlock, Na |
| Aroa Biosurgery Incorporated | $34.38 | 2025 | |
| Biohorizons Implant Systems INC. | $19.94 | 2022 | |
| 3m Company | $15.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Deyoung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.